Journey Medical (DERM) Share-based Compensation (2020 - 2026)
Journey Medical's (DERM) quarterly Share-based Compensation came in at $989000.0 in Q1 2026, down 25.25% YoY from $1.3 million in Q1 2025, and down 44.28% on a QoQ basis from $1.8 million in Q4 2025.
Journey Medical (DERM) Share-based Compensation (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Share-based Compensation data on file, last reported at $989000.0 in Q1 2026.
- Quarterly Share-based Compensation fell 25.25% year-over-year to $989000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 million (down 1.23% YoY) and the FY2025 annual result came in at $6.3 million, down 30.33% from the prior year.
- Share-based Compensation retreated to $989000.0 in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $2.5 million in Q2 2025 to a low of $529000.0 in Q4 2023.
- A 5-year average of $1.3 million and a median of $1.4 million in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation surged 17875.0% — and 2023, when it plunged 63.26%.
- Tracing DERM's Share-based Compensation over 5 years: stood at $1.4 million in 2022, then sank by 63.26% to $529000.0 in 2023, then surged by 160.49% to $1.4 million in 2024, then rose by 28.81% to $1.8 million in 2025, then tumbled by 44.28% to $989000.0 in 2026.
- The last three Share-based Compensation figures came in at $989000.0 (Q1 2026), $1.8 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | 1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.44 Mn |
| Jun 30, 2026 | 1.44 Mn |
| Mar 31, 2026 | 989,000.00 |
| Mar 31, 2026 | 989,000.00 |
| Dec 31, 2025 | 1.78 Mn |
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.41 Mn |